Articles
30.11.2022
Reflecting on the Pricing & Market Access tre...

Our experts reflect on the trends that shaped the European pricing and market access landscape in 20...

Read more
Publications
07.11.2022
ISPOR 2022 Plenary Session 1 - HTA and Regulation

Our experts provide a detailed summary of Plenary Session 1 at ISPOR 2022 on the Convergence of HTA ...

Read more
News
02.11.2022
PMA Insights: Week 44

We summarise four handpicked articles from pharmaceutical, pricing and market access that are worth ...

Read more
Insider Insights
01.11.2022
A winter of discontent? European pharmaceutical so...

EUCOPE and EFPIA have issued a joint statement expressing concerns regarding the implementation of t...

Read more
Articles
24.08.2022
EU Joint HTA: What’s going on and what does it m...

EUnetHTA and the EU Joint HTA Process Originally set up in 2006, EUnetHTA was established to facilit...

Read more
Articles
24.08.2022
Seeking early advice from the EMA and multiple HTA...

Introduction Achieving access to patients for innovative treatments is becoming a significant challe...

Read more
Articles
24.08.2022
EU Joint HTA: How should manufacturers adapt to th...

EUnetHTA and the EU Joint HTA Process EUnetHTA was established in 2006 to facilitate information sha...

Read more
Articles
03.12.2021
Reflecting on the Pricing & Market Access tre...

Our experts reflect on the pricing and market access trends that shaped the European Landscape in 20...

Read more
Articles
04.12.2020
What are the 5 Pricing and Market Access trends th...

Our experts predict the 5 trends they think will dominate the European pricing and market access lan...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.